[1]
O. M. Shaheed, M. Y. Shaker, and M. M. AlRufaie, “Interaction between TNF inhibitors and serum IL-17 levels and susceptibility to rheumatoid arthritis”, Curr. Issues Pharm. Med. Sci., vol. 38, no. 4 (AOP), Jan. 2026, doi: 10.12923/.